Prevalence of rheumatoid arthritis in France: 2001, Annals of the Rheumatic Diseases, vol.64, issue.10, pp.1427-1457, 2001. ,
DOI : 10.1136/ard.2004.029199
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review182-8. 3. van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis, Semin. Arthritis Rheum. Br J Rheumatol, vol.3634, issue.3 2, pp.74-82, 1995. ,
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1580-1588, 2010. ,
DOI : 10.1136/ard.2010.138461
URL : https://hal.archives-ouvertes.fr/hal-01557559
The impact of rheumatoid arthritis and treatment on patients' lives, Clin. Exp. Rheumatol, vol.28, issue.3, pp.32-40, 2010. ,
Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment, Annals of the Rheumatic Diseases, vol.71, issue.7, pp.1143-50, 2012. ,
DOI : 10.1136/annrheumdis-2011-200387
Rheumatoid Arthritis (RA) Impact on Work and RA-Related Indirect Costs during the First Three Years after RA Diagnosis. An Economic Analysis from the ESPOIR Cohort, Atlanta (GA, 2010. ,
Disease activity and disability in women and men with early rheumatoid arthritis (RA): An 8-year followup of a Swedish early RA project 2012 août, Arthritis Care Res, vol.64, issue.8, pp.1101-1108 ,
Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality, J Rheumatol, vol.69, pp.3-8, 2004. ,
Mortality in the rheumatic diseases, Arthritis Care & Research, vol.22, issue.4, pp.229-270, 1995. ,
DOI : 10.7326/0003-4819-73-6-929
Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992, Scand J Rheumatol, vol.29, issue.1, pp.29-37, 2000. ,
Introduction to health economics for the medical practitioner, Postgraduate Medical Journal, vol.79, issue.929, pp.147-50, 2003. ,
DOI : 10.1136/pmj.79.929.147
Methods for economic evaluation of health care programmes, 2005. ,
Principles of economic evaluation for health care programs, J Rheumatol, vol.22, issue.7, pp.1399-402, 1995. ,
An Introduction to Markov Modelling for Economic Evaluation, PharmacoEconomics, vol.13, issue.4, pp.397-409, 1998. ,
DOI : 10.2165/00019053-199813040-00003
Cost-of-illness studies: fact or fiction?, The Lancet, vol.344, issue.8936, pp.1519-1539, 1994. ,
DOI : 10.1016/S0140-6736(94)90342-5
Issues of consensus and debate for economic evaluation in rheumatology, J Rheumatol, vol.28, issue.3, pp.642-649, 2001. ,
Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology, Annals of the Rheumatic Diseases, vol.61, issue.4, pp.370-373, 2002. ,
DOI : 10.1136/ard.61.4.370
Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics, Appl Health Econ Health Policy, vol.2, issue.4, pp.213-237, 2003. ,
Health-related quality of life--an introduction, Am J Manag Care, vol.13, pp.218-223, 2007. ,
Theory of Games and Economic Behavior (Commemorative Edition) Princeton University Press, 2007. ,
A utility maximization model for evaluation of health care programs, Health Serv Res, vol.7, issue.2, pp.118-151, 1972. ,
Perspectives on utility theory, Operations Research, pp.179-83, 1986. ,
Foundations of Cost-Effectiveness Analysis for Health and Medical Practices, New England Journal of Medicine, vol.296, issue.13, pp.716-737, 1977. ,
DOI : 10.1056/NEJM197703312961304
Economics of coronary artery bypass grafting., BMJ, vol.291, issue.6491, pp.326-335 ,
DOI : 10.1136/bmj.291.6491.326
Measurement of health state utilities for economic appraisal, Journal of Health Economics, vol.5, issue.1, pp.1-30, 1986. ,
DOI : 10.1016/0167-6296(86)90020-2
Health related utility measurement: an introduction, J. Rheumatol, vol.22, issue.6, pp.1197-1206, 1995. ,
DOI : 10.1016/0738-3991(93)90128-j
The standard gamble showed better construct validity than the time trade-off, Journal of Clinical Epidemiology, vol.60, issue.10, pp.1029-1062, 2007. ,
DOI : 10.1016/j.jclinepi.2007.03.001
Methods for the economic evaluation of health care programmes, 1987. ,
Methodology for measuring health-state preferences???II: Scaling methods, Journal of Clinical Epidemiology, vol.42, issue.5, pp.459-71, 1989. ,
DOI : 10.1016/0895-4356(89)90136-4
Time preference, duration and health state valuations. Health Econ, pp.289-99, 1995. ,
The estimation of a preference-based measure of health from the SF-36, Journal of Health Economics, vol.21, issue.2, pp.271-92, 2002. ,
DOI : 10.1016/S0167-6296(01)00130-8
The Health Utilities Index (HUI): concepts, measurement properties and applications, Health and Quality of Life Outcomes, vol.1, issue.1, p.54, 2003. ,
DOI : 10.1186/1477-7525-1-54
Modeling valuations for EuroQol health states. Med Care, pp.1095-108, 1997. ,
Valuing EQ-5D using Time Trade-Off in France, Eur J Health Econ, 2011. ,
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, pp.473-83, 1992. ,
The French SF-36 Health Survey, Journal of Clinical Epidemiology, vol.51, issue.11, pp.1013-1036, 1998. ,
DOI : 10.1016/S0895-4356(98)00093-6
Assumptions of the QALY procedure, Social Science & Medicine, vol.29, issue.3, pp.469-77, 1989. ,
DOI : 10.1016/0277-9536(89)90296-7
[QALYS or not QALYS: that is the question?]. Rev Epidemiol Sante Publique, pp.573-83, 1995. ,
Distinguishing health expectancies and health-adjusted life expectancies from quality-adjusted life years., American Journal of Public Health, vol.83, issue.6, pp.797-805, 1993. ,
DOI : 10.2105/AJPH.83.6.797
The value of utility: assumptions underlying preferences and quality adjusted life years, J Rheumatol, vol.26, issue.9, pp.1861-1864, 1999. ,
Multimorbidity in General Practice: Prevalence, Incidence, and Determinants of Co-Occurring Chronic and Recurrent Diseases, Journal of Clinical Epidemiology, vol.51, issue.5, pp.367-75, 1998. ,
DOI : 10.1016/S0895-4356(97)00306-5
Multimorbidity and quality of life in primary care: a systematic review, Health and Quality of Life Outcomes, vol.2, issue.1, p.51, 2004. ,
DOI : 10.1186/1477-7525-2-51
Valuing Health for Clinical and Economic Decisions: Directions Relevant for Rheumatologists, The Journal of Rheumatology, vol.38, issue.8, pp.1770-1775, 2011. ,
DOI : 10.3899/jrheum.110404
Foundations of Cost-Effectiveness Analysis for Health and Medical Practices, New England Journal of Medicine, vol.296, issue.13, pp.716-737, 1977. ,
DOI : 10.1056/NEJM197703312961304
The QALY Model and Individual Preferences for Health States and Health Profiles over Time: A Systematic Review of the Literature, Medical Decision Making, vol.25, issue.4, pp.460-467, 2005. ,
DOI : 10.1006/jmps.1999.1256
Modeling Valuations for EuroQol Health States, Medical Care, vol.35, issue.11, pp.1095-1108, 1997. ,
DOI : 10.1097/00005650-199711000-00002
The estimation of a preference-based measure of health from the SF-36, Journal of Health Economics, vol.21, issue.2, pp.271-292, 2002. ,
DOI : 10.1016/S0167-6296(01)00130-8
Health-related quality of life--an introduction, Am. J. Manag. Care, vol.13, pp.218-241, 2007. ,
The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007. ,
DOI : 10.1016/j.jbspin.2007.06.001
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.20, issue.1, pp.44-48, 1995. ,
DOI : 10.1002/art.1780281203
Measurement of patient outcome in arthritis, Arthritis & Rheumatism, vol.33, issue.2, pp.137-182, 1980. ,
DOI : 10.1001/jama.1963.03060120024016
A comparison of the performance of the EQ???5D and SF???6D for individuals aged ??? 45 years, Health Economics, vol.30, issue.2, pp.815-832, 2008. ,
DOI : 10.3310/hta9320
Valuing EQ-5D using Time Trade-Off in France, Eur J Health Econ, 2011. ,
???Death??? and the Valuation of Health-Related Quality of Life, Medical Care, vol.39, issue.3, pp.217-244, 2001. ,
DOI : 10.1097/00005650-200103000-00003
Sensitivity and perspective in the valuation of health status: whose values count?, Health Economics, vol.13, issue.2, pp.109-135, 2000. ,
DOI : 10.1177/0272989X9301300210
Why Do Patients with Inflammatory Arthritis Often Score States ???Worse than Death??? on the EQ-5D? An Investigation of the EQ-5D Classification System, Value in Health, vol.12, issue.6, pp.1026-1060, 2009. ,
DOI : 10.1111/j.1524-4733.2009.00565.x
Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis, PharmacoEconomics, vol.26, issue.9, pp.477-87, 2010. ,
DOI : 10.1093/rheumatology/35.suppl_2.4
A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States, Medical Decision Making, vol.18, issue.1, pp.7-16, 2001. ,
DOI : 10.1002/(SICI)1099-1050(199909)8:6<541::AID-HEC464>3.0.CO;2-8
Estimating an EQ-5D population value set: the case of Japan, Health Economics, vol.51, issue.4, pp.341-53, 2002. ,
DOI : 10.1016/S0895-4356(98)00095-X
Health-Related Quality of Life (HR-QOL) and Regulatory Issues, PharmacoEconomics, vol.279, issue.6, pp.187-95, 2001. ,
DOI : 10.2165/00019053-200119020-00005
97 EQ-5D score ACR/EULAR criteria for rheumatoid arthritis, no. (%) 0 ,
positive > 50 U/ml) detected in all patients by the same technique in a central lab ,
3%) had erosions on hands and/or feet at baseline. 1.98±0, p.160 ,
Modeling Valuations for EuroQol Health States, Medical Care, vol.35, issue.11, pp.1095-1108, 1997. ,
DOI : 10.1097/00005650-199711000-00002
The estimation of a preference-based measure of health from the SF-36, Journal of Health Economics, vol.21, issue.2, pp.271-292, 2002. ,
DOI : 10.1016/S0167-6296(01)00130-8
Health-related quality of life--an introduction, Am. J. Manag. Care, vol.13, pp.218-241, 2007. ,
The QALY Model and Individual Preferences for Health States and Health Profiles over Time: A Systematic Review of the Literature, Medical Decision Making, vol.25, issue.4, pp.460-467, 2005. ,
DOI : 10.1006/jmps.1999.1256
Variation in the Estimation of Quality-adjusted Life-years by Different Preference-based Instruments, Medical Care, vol.41, issue.7, pp.791-801, 2003. ,
DOI : 10.1097/00005650-200307000-00003
Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.69, issue.10 ,
DOI : 10.1136/ard.2009.124099
Comparison of the EuroQol and short form 6D in Singapore multiethnic asian knee osteoarthritis patients scheduled for total knee replacement, Arthritis & Rheumatism, vol.22, issue.6, pp.1043-1052, 2007. ,
DOI : 10.1016/S0140-6736(86)90837-8
A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis, Medical Care, vol.42, issue.11, pp.1125-1131, 2004. ,
DOI : 10.1097/00005650-200411000-00012
A comparison of the performance of the EQ???5D and SF???6D for individuals aged ??? 45 years, Health Economics, vol.30, issue.2, pp.815-832, 2008. ,
DOI : 10.3310/hta9320
Comparison of the EQ-5D and the Short Form 6D utility measures in French patients with early arthritis: Results from the ESPOIR cohort, J Rheumatol, 2011. ,
The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007. ,
DOI : 10.1016/j.jbspin.2007.06.001
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.20, issue.1 ,
DOI : 10.1002/art.1780281203
Measurement of patient outcome in arthritis, Arthritis & Rheumatism, vol.33, issue.2, pp.137-182, 1980. ,
DOI : 10.1001/jama.1963.03060120024016
Sany J, and the French Quality of Life in Rheumatology Group. The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2, Arthritis Rheum, vol.40, pp.1267-74, 1997. ,
The MOS 36-item short-form health survey (SF-36 ,
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D, Quality of Life Research, vol.2, issue.5, pp.1523-1555, 2005. ,
DOI : 10.1136/bmj.316.7139.1236
SF-6D utility index as measure of minimally important difference in health status change, Journal of the American Pharmacists Association, vol.52, issue.1, pp.34-42, 2003. ,
DOI : 10.1331/JAPhA.2012.10114
Valuing health states: A comparison of methods, Journal of Health Economics, vol.15, issue.2 ,
DOI : 10.1016/0167-6296(95)00038-0
Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets, Journal of Health Economics, vol.25, issue.2, pp.334-346, 2006. ,
DOI : 10.1016/j.jhealeco.2005.09.003
Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort, Rheumatology, vol.19, issue.2 ,
DOI : 10.2165/00019053-200119020-00005
URL : https://hal.archives-ouvertes.fr/hal-01044491
Why Do Patients with Inflammatory Arthritis Often Score States ???Worse than Death??? on the EQ-5D? An Investigation of the EQ-5D Classification System, Value in Health, vol.12, issue.6, pp.1026-1060, 2009. ,
DOI : 10.1111/j.1524-4733.2009.00565.x
A comparison of the EQ-5D and SF-6D across seven patient groups, Health Economics, vol.13, issue.9, pp.873-884, 2004. ,
DOI : 10.1002/hec.866
Valuing EQ-5D using Time Trade-Off in France, Eur J Health Econ, 2011. ,
DiaSorin, France; positive > 50 U/ml) were detected in all patients using the same technique in a central lab ,
France Key words: utility, SF-6D, early arthritis Institutions to which the work should be attributed ,
MD, PhD Corresponding author: Dr Cécile Gaujoux-Viala, pp.33-34 ,
-mental scores explained 49.3 and 14.5% of the variance respectively (table 3) At 6 months visit and further time-points, the determinants of SF-6D were almost the same. Compared to baseline results, the part of the variance they explained dramatically changed (Figure 1). HAQ and AIMS2-SF-mental scores ,
Measurement of health state utilities for economic appraisal, Journal of Health Economics, vol.5, issue.1, pp.1-30, 1986. ,
DOI : 10.1016/0167-6296(86)90020-2
Foundations of Cost-Effectiveness Analysis for Health and Medical Practices, New England Journal of Medicine, vol.296, issue.13, pp.716-737, 1977. ,
DOI : 10.1056/NEJM197703312961304
Health related utility measurement: an introduction, J. Rheumatol, vol.22, issue.6, pp.1197-1206, 1995. ,
Methods for economic evaluation of health care programmes, 2005. ,
The estimation of a preference-based measure of health from the SF-36, Journal of Health Economics, vol.21, issue.2, pp.271-92, 2002. ,
DOI : 10.1016/S0167-6296(01)00130-8
Health-related quality of life--an introduction, Am J Manag Care, vol.13, pp.218-223, 2007. ,
Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.69, issue.10 ,
DOI : 10.1136/ard.2009.124099
Not all ???quality-adjusted life years??? are equal, Journal of Clinical Epidemiology, vol.60, issue.6, pp.616-640, 2007. ,
DOI : 10.1016/j.jclinepi.2006.09.006
Comparison of the EQ-5D and the SF-6D Utility Measures in 813 Patients with Early Arthritis: Results from the ESPOIR Cohort, The Journal of Rheumatology, vol.38, issue.8, pp.1576-84, 2011. ,
DOI : 10.3899/jrheum.101006
URL : https://hal.archives-ouvertes.fr/hal-00790808
Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis Rheum, août, vol.1557, issue.6, pp.963-71, 2007. ,
A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures, The European Journal of Health Economics, vol.22, issue.2 ,
DOI : 10.1177/02729890122062352
The Beaver Dam Health Outcomes study, Medical Decision Making, vol.23, issue.2, pp.89-102, 1993. ,
DOI : 10.1016/S0161-6420(91)32137-7
The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007. ,
DOI : 10.1016/j.jbspin.2007.06.001
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.20, issue.1, pp.44-52, 1995. ,
DOI : 10.1002/art.1780281203
Measurement of patient outcome in arthritis, Arthritis & Rheumatism, vol.33, issue.2, pp.137-182, 1980. ,
DOI : 10.1001/jama.1963.03060120024016
The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2. French Quality of Life in Rheumatology Group, Arthritis Rheum, vol.40, issue.7, pp.1267-74, 1997. ,
Modeling valuations for EuroQol health states. Med Care, pp.1095-108, 1997. ,
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, pp.473-83, 1992. ,
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D, Quality of Life Research, vol.2, issue.5, pp.1523-1555, 2005. ,
DOI : 10.1136/bmj.316.7139.1236
SF-6D utility index as measure of minimally important difference in health status change, Journal of the American Pharmacists Association, vol.52, issue.1, pp.34-42, 2003. ,
DOI : 10.1331/JAPhA.2012.10114
Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort, Rheumatology, vol.19, issue.2 ,
DOI : 10.2165/00019053-200119020-00005
URL : https://hal.archives-ouvertes.fr/hal-01044491
A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ, pp.873-84, 2004. ,
The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis, Health Technology Assessment, vol.8, issue.11, pp.1-91, 2004. ,
DOI : 10.3310/hta8110
Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK. Rheumatology (Oxford), pp.62-72, 2004. ,
Validating and Assessing the Sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in Patients with Early Aggressive Rheumatoid Arthritis, The Journal of Rheumatology, vol.36, issue.6, pp.1150-1157, 2009. ,
DOI : 10.3899/jrheum.080959
Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ, Annals of the Rheumatic Diseases, vol.66, issue.11, pp.1534-1541, 2007. ,
DOI : 10.1136/ard.2007.073726
Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis, Health and Quality of Life Outcomes, vol.8, issue.1, p.21, 2010. ,
DOI : 10.1186/1477-7525-8-21
Valuing EQ-5D using Time Trade-Off in France, Eur J Health Econ, 2011. ,
IgM and IgA rheumatoid factor (Elisa, Menarini, France; positive >9 UI/ml) and anti-CCP2 antibodies (ELISA, DiaSorin, France; positive > 50 U/ml) were detected in all patients using the same technique in a central lab ,